[Corrigendum] Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF‑1 pathway inhibition in vivo

• Authors:
  • Xiaoqing Jia
  • Jingyi Cheng
  • Zhenzhou Shen
  • Zhimin Shao
  • Guangyu Liu

• View Affiliations

  
  Affiliations: Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China
• Published online on: October 9, 2024     https://doi.org/10.3892/mmr.2024.13357
• Article Number: 233

• Copyright : © Jia et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Article

View Figures

Figure 1

Figure 2